NEWS
ONVY RAISES OVER US $ 2MN TO REVOLUTIONISE AI-POWERED HEALTH COACHING
ONVY HealthTech Group GmbH , a Munich-based pioneer in AI-driven precision health , has successfully raised over US $ 2 million in a seed extension financing round . The round was led by Voloridge Health , LLC an affiliate of Voloridge Investment Management , LLC a quantitative hedge fund manager renowned for its use of data science and predictive modelling to develop sophisticated systematic investment strategies . This investment will accelerate ONVY ’ s expansion as it scales its AI-driven health coaching platform to power hyperpersonalised health engagement at scale .
Adrian Kochsiek , Founder and CEO of ONVY , said : “ The future of health is real-time , hyper-personalised , and AIdriven . Yet , the industry still relies on outdated , delayed and one-size-fits-all approaches . At ONVY , we are changing that . Our platform transforms raw health data into instant , tailored guidance – empowering users to take
action when it matters most . With this investment , we are scaling AI-driven precision health to revolutionise how individuals and businesses engage with well-being .”
HEARTX CARDIOVASCULAR ACCELERATOR SEEKS INNOVATIVE EARLY-STAGE COMPANIES FOR 2025 PROGRAMME
HealthTech Arkansas and MedAxiom have launched year four of HeartX , a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished , early-stage companies bringing new cardiovascular innovations to the market .
Applications for the 2025 HeartX cohort opened on 1 February , with five companies to be selected in September 2025 . The programme is seeking companies in three categories : digital health and software , medical devices , and diagnostic platforms . Each company will receive US $ 150,000 of investment capital and is guaranteed at least one pilot project or clinical study with cardiology practices in Arkansas and across the country .
“ The HeartX programme exemplifies our commitment to bridging the gap between promising cardiovascular innovations and real-world clinical validation ,” said Jeff Stinson , director of HealthTech Arkansas . “ By guaranteeing early-stage companies direct access to leading cardiology practices for pilots and clinical trials , we ’ re enabling these innovators to rapidly demonstrate impact , refine their solutions , and ultimately improve patient outcomes . We ’ re proud to collaborate with MedAxiom again to bring transformative technologies to market .”
10 www . intelligenthealth . tech